Hepatitis B (HBV): Anti HbcorAg

400 UAH

Infection panel/Hepatitis/Hepatitis B (HBV)

Products that will be added:

  • Blood collection with disposable Vacuette, BD Vacutainer systems
Description
4.9/5 - (1341 votes)

Hepatitis B (HBV) is a serious infectious disease of the liver caused by the hepatitis B virus (HBV). The disease can have a variety of clinical manifestations, ranging from asymptomatic carriage to acute and chronic hepatitis, cirrhosis, and liver failure. Various tests are used to diagnose and assess the extent of infection, including the infection panel and the Anti HbcorAg assay.

The Hepatitis B Infection Panel includes various biomarkers and antibodies that help determine the presence or absence of the Hepatitis B virus in the patient's body, as well as assess the stage of the disease. One of the important components of this panel is Anti HbcorAg, which indicates the presence of antibodies to the Hepatitis B virus core.

Anti HbcorAg, or antibodies to the HBV core, is one of the key indicators in the diagnosis of hepatitis B infection. These antibodies are produced in the body in response to the core antigens of the virus. Their presence indicates that the body has been in contact with the hepatitis B virus, even if the infection itself has already been overcome or has been transferred in the past.

Anti HbcorAg is divided into two types: IgM and IgG. IgM antibodies indicate an active or recent infection with hepatitis B. If IgM Anti HbcorAg is detected in the blood, it may indicate an acute stage of the disease. On the other hand, IgG Anti HbcorAg indicates that the infection has passed or that the person has been vaccinated against hepatitis B.

In summary, the Hepatitis B Infection Panel with Anti HbcorAg is an important tool for the diagnosis and monitoring of this serious disease. It allows doctors to establish the presence of the hepatitis B virus, assess the degree of infection activity, and determine the stage of the disease. Timely diagnosis and treatment of hepatitis B can significantly improve the prognosis of the disease and prevent the development of complications such as cirrhosis and liver failure.

It is important to emphasize that vaccination against hepatitis B is an effective means of preventing infection. Regular medical check-ups and adherence to personal hygiene rules are also key aspects in maintaining liver health and preventing hepatitis B infection.

Additional information
Execution time

1 day

Type of biomaterial

Venous blood